Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency
The first subjects with deficiency of mitochondrial tryptophanyl-tRNA synthetase (WARS2) were reported in 2017. Their clinical characteristics can be subdivided into three phenotypes (neonatal phenotype, sever...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Elise Vantroys, Jo él Smet, Arnaud V. Vanlander, Sarah Vergult, Ruth De Bruyne, Frank Roels, Hedwig Stepman, Herbert Roeyers, Björn Menten and Rudy Van Coster Tags: Research Source Type: research
More News: Brain | Children | Internal Medicine | Men | Mitochondrial Disease | Neurology | Perinatology & Neonatology | Rare Diseases